Peter Wilden
Chairman at POLYPEPTIDE GROUP AG
Net worth: 282 647 $ as of 2024-03-30
Profile
Peter Wilden is currently the Vice Chairman-Supervisory Board at Schlumberger GmbH since 2014.
He is also the Executive Chairman at Ferring International Center SA since 2002.
Additionally, he holds the position of Chairman at PolyPeptide Laboratories Holding (PPL) AB.
Furthermore, he is the Chairman at PolyPeptide Group AG starting from 2021.
Dr. Wilden is the Director at Project HOPE-The-People-To-People Health Foundation, Inc. since 2012 and the Director at Ferring Laboratories Ltd.
since 2004.
He is also the Managing Director at Nesos Vermögensverwaltung GmbH and a Member-Supervisory Board at Ferring GmbH.
In the past, Dr. Wilden worked as a Director at Lonza Group AG from 2004 to 2014.
He was also a Director at Aureum Realwert AG from 1999 to 2002 and Director-Group Finance at Ferring BV from 1995 to 2000.
He served as a Director at Trizell Holding SA from 2014 to 2021 and as the Chief Financial Officer & Executive Vice President at Ferring Pharmaceuticals A from 1991 to 2017.
Additionally, he worked as a Management Assistant at Krupp Mak Maschinenbau GmbH from 1986 to 1988 and as a Scientific Assistant-Information Technology Group at Kiel Institute for the World Economy in 1986.
Dr. Wilden was also the VP-Finance, Accounting & Technical Operations at FERRING Arzneimittel GmbH (Germany) from 1991 to 1996.
Dr. Wilden holds a doctorate degree from the University of Kiel, which he obtained in 1991.
He also has an MBA from the University of Kiel, which he received in 1986.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
POLYPEPTIDE GROUP AG
0.03% | 2022-12-30 | 8,402 ( 0.03% ) | 282 647 $ | 2024-03-30 |
Peter Wilden active positions
| Companies | Position | Start |
|---|---|---|
| SCHLUMBERGER AG | Director/Board Member | 2014-09-10 |
| POLYPEPTIDE GROUP AG | Chairman | 2021-03-31 |
Ferring GmbH
 Ferring GmbH Pharmaceuticals: MajorHealth Technology Ferring GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Kiel, Germany. The company was founded in 1990. The CEO is Claus Tollnick. | Director/Board Member | - |
Nesos Vermögensverwaltung GmbH
 Nesos Vermögensverwaltung GmbH Investment ManagersFinance Nesos Vermögensverwaltung GmbH is a private company based in Alkersum, Germany. Nesos Vermögensverwaltung GmbH provides asset management services. The German company was founded in 1990 and is led by CEO Peter Wilden. | Chief Executive Officer | - |
Ferring International Center SA
 Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Chairman | 2001-12-31 |
PolyPeptide Laboratories Holding (PPL) AB
 PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Chairman | - |
Ferring Laboratories Ltd.
 Ferring Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Laboratories Ltd. is a British pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The private company is based in Middlesex, UK and was founded in 1980. | Director/Board Member | 2004-06-30 |
Project HOPE-The-People-To-People HealthFoundation, Inc.
 Project HOPE-The-People-To-People HealthFoundation, Inc. Medical/Nursing ServicesHealth Services Project HOPE-The-People-To-People HealthFoundation, Inc. provides solutions to health problems. The firm trains health professionals and build medical facilities in areas devastated by conflict, natural disasters, and poverty. It addresses infectious diseases, health professional education, women's and children's health, humanitarian assistance, and the need for health systems and facilities. The company was founded by William B. Walsh in 1958 and is headquartered in Millwood, VA. | Director/Board Member | 2011-12-31 |
Former positions of Peter Wilden
| Companies | Position | End |
|---|---|---|
| Trizell Holding SA | Director/Board Member | 2021-05-31 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Peter Wilden
| University of Kiel | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| LONZA GROUP AG | Health Technology |
| POLYPEPTIDE GROUP AG | Health Technology |
| Private companies | 14 |
|---|---|
Schlumberger GmbH /Austria/
 Schlumberger GmbH /Austria/ Beverages: AlcoholicConsumer Non-Durables Schlumberger AG operates as a holding company, which engages in the production, sale, and distribution of alcoholic and non-alcoholic beverages. The firm offers wine, sparkling wine, champagne, and spirituous beverages. It distributes its products under the Gurktaler Alpenkräuter, Rossbacher, Underberg, Asbach, Bols, Metaxa, Leibwächter, Nonino, Stock, Remy Martin, Stolichnaya, XUXU, evian, Volvic, Badoit, Riemerschmid, and SENS brands. The company was founded by Robert Alwin Schlumberger in 1842 and is headquartered in Vienna, Austria. | Consumer Non-Durables |
Aureum Realwert AG
 Aureum Realwert AG Financial ConglomeratesFinance Aureum Realwert AG engages in the acquisition, administration and sale of financial assets such as investments in other companies. It invests in real assets including precious metals, raw materials, and real estate. The company was founded by Wolfgang Kuennecke on November 18, 1991 and is headquartered in Berlin, Germany. | Finance |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Health Technology |
Project HOPE-The-People-To-People HealthFoundation, Inc.
Project HOPE-The-People-To-People HealthFoundation, Inc. Medical/Nursing ServicesHealth Services Project HOPE-The-People-To-People HealthFoundation, Inc. provides solutions to health problems. The firm trains health professionals and build medical facilities in areas devastated by conflict, natural disasters, and poverty. It addresses infectious diseases, health professional education, women's and children's health, humanitarian assistance, and the need for health systems and facilities. The company was founded by William B. Walsh in 1958 and is headquartered in Millwood, VA. | Health Services |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Ferring International Center SA develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics. It also specializes in the fields of gastroenterology and endocrinology. The company was founded in 1950 and is headquartered in Saint-Prex, Switzerland. | Health Technology |
Ferring BV
 Ferring BV Pharmaceuticals: MajorHealth Technology Ferring BV offers pharmaceutical products. It offers medicines in Gynaecology, Gastroenterology, Endocrinology and Urology. The company was founded in 1984 and is headquartered in Hoofddorp, Netherlands. | Health Technology |
| Krupp Mak Maschinenbau GmbH | |
PolyPeptide Laboratories Holding (PPL) AB
PolyPeptide Laboratories Holding (PPL) AB Financial ConglomeratesFinance PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden. | Finance |
Kiel Institute for the World Economy
 Kiel Institute for the World Economy Investment ManagersFinance The Kiel Institute for the World Economy, founded in 1914, provides investment research. The private company is based in Kiel, Germany. | Finance |
Ferring Laboratories Ltd.
Ferring Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Part of Ferring Holding SA, Ferring Laboratories Ltd. is a British pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The private company is based in Middlesex, UK and was founded in 1980. | Health Technology |
FERRING Arzneimittel GmbH (Germany)
 FERRING Arzneimittel GmbH (Germany) Pharmaceuticals: MajorHealth Technology PART OF FERRING HOLDING SA\: Ferring Arzneimittel GmbH is a pharmaceutical company based in Kiel, Germany. Ferring Arzneimittel GmbH is part of Ferring Holding SA and specializes in prescription drugs. The company's website contains information about their products, which is only accessible to medical professionals due to German regulations. The private company was founded in 1973 by Otto Paulsen and the CEO is Thomas Leiers. | Health Technology |
Nesos Vermögensverwaltung GmbH
Nesos Vermögensverwaltung GmbH Investment ManagersFinance Nesos Vermögensverwaltung GmbH is a private company based in Alkersum, Germany. Nesos Vermögensverwaltung GmbH provides asset management services. The German company was founded in 1990 and is led by CEO Peter Wilden. | Finance |
| Trizell Holding SA | |
Ferring GmbH
Ferring GmbH Pharmaceuticals: MajorHealth Technology Ferring GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Kiel, Germany. The company was founded in 1990. The CEO is Claus Tollnick. | Health Technology |
- Stock Market
- Insiders
- Peter Wilden
